5 Results for "

G4/hTERT-IN-4

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "G4/hTERT-IN-4" in MCE Product Catalog:

Cat. No.: HY-170643
CAS No.: 3096240-29-5
Target:  

G-quadruplex

Research Areas:  

Cancer

G4/hTERT-IN-4 (compound b4) is a potent inhibitor of G4/hTERT. G4/hTERT-IN-4 plays an important role in cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148012
CAS No.: 2546091-70-5
Purity:  98.46%
Synonyms: QN-302
Target:  

G-quadruplex

Research Areas:  

Cancer

SOP1812 (QN-302) is a naphthalene diimide (ND) derivative with anti-tumor activity. SOP1812 binds to quadruplex arrangements (G4s), and down-regulates several cancer gene pathways. SOP1812 shows great affinity to hTERT G4 and HuTel21 G4 with KD values of 4.9 and 28.4 nM, respectively. SOP1812 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-162688
Research Areas:  

Others

Anticancer agent 239 (Compound 5) is a ligand of hTERT promoter G-quadruplex DNA structures (hTERT G4) (Kd = 1.1 μM), and downregulates hTERT expression. Anticancer agent 239 decreases telomerase activity, shortens telomere length, and induces DNA damage, acute cellular senescence, and apoptosis. Anticancer agent 239 causes mitochondrial dysfunction, disrupts iron metabolism and activates ferroptosis in cancer cells. Anticancer agent 239 inhibits tumor growth in MDA-MB-231 xenograft mouse model .
loading...
    loading...
Cat. No.: HY-179480
G-quadruplex ligand 4 is a chromenone derivative and is a human telomerase reverse transcriptase (hTERT) G4 ligand. G-quadruplex ligand 4 downregulates hTERT expression and exhibits notable cytotoxicity towards triple-negative breast cancer (TNBC) cell lines. G-quadruplex ligand 4 can cause S/G2 cell cycle arrest and induce apoptosis. G-quadruplex ligand 4 downregulates the expression of hTERT, KRAS, and BCL-2. G-quadruplex ligand 4 can be used for the research of TNBC .
loading...
    loading...
Cat. No.: HY-100832A
CAS No.: 1872382-48-3
Research Areas:  

Cancer

UNC3866 TFA is a potent antagonist of the CBX7-H3 interaction as determined by AlphaScreen (IC50=66±1.2 nM) and is more than 100-fold selective for CBX7 over the other nine members of this methyl-lysine (Kme) reader panel.
loading...
    loading...